EUVIMEDEUVIMED entdecken
Crossref

Impact of Metabolic Syndrome on Myocardial Status in ICU Patients.

Mohamed Wasfy, Mohamed Farag

Clinical Cardiology and Cardiovascular Interventions · 22.04.2026 · 09 (06) · 01-03

DOI: 10.31579/2641-0419/550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Cardiology and Cardiovascular Interventions, online erschienen am 22.04.2026. Verfasst von Mohamed Wasfy und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fujairah Hospital, United Arab Emirates.

Background

Metabolic Syndrome (MetS) is a highly prevalent condition among patients with acute myocardial infarction (AMI) in the intensive care unit (ICU), yet its direct impact on in- hospital outcomes remain a subject of debate. This systematic review aims to synthesize the current evidence on the prevalence of MetS in critically ill AMI patients and its association with clinical severity and in-hospital mortality.

Methods

This is a systematic observational study. Data on patients’ demographics, clinical characteristics, and clinical outcomes were systematically extracted and synthesized. The study focused on prevalence rates, patient characteristics including age, gender, body mass index, waist circumference, and comorbidities, as well as in-hospital outcomes such as mortality, heart failure, and major adverse cardiovascular events.

Results

The prevalence of MetS in patients with AMI in the ICU setting is consistently high, ranging from 46% to 68.3% across different populations [1, 2]. Patients with MetS are more likely to be female and present with a higher body mass index (BMI), larger waist circumference, and a greater incidence of hypertension and diabetes. While some studies report no significant increase in all-cause in-hospital mortality, others indicate a significantly higher rate of cardiovascular mortality (P = .03) and an increased risk of complications such as congestive heart failure and recurrent myocardial ischemia [1, 3]. Specific components of MetS, notably hyperglycemia and a BMI ≥28 kg/m², have been identified as independent predictors of major adverse cardiovascular events (MACE) [2]. The pathophysiological mechanisms underlying these outcomes demonstrate the complex interplay between MetS components and myocardial dysfunction.

Conclusion

Metabolic Syndrome is a major health burden in critically ill patients with AMI, associated with a higher risk of specific in-hospital complications, even if its role in all- cause mortality is not definitively established. The underlying pathophysiology involves a complex interplay of systemic inflammation, endothelial dysfunction, and a prothrombotic state, which collectively drive myocardial fibrosis and ventricular hypertrophy, culminating in myocardial dysfunction. These findings underscore the critical need for early identification and aggressive management of MetS and its components to improve outcomes in this high-risk population. Further large-scale prospective studies are warranted to clarify the prognostic implications of MetS in the ICU.

Zitieren

APA

Wasfy, M., & Farag, M. (2026). Impact of Metabolic Syndrome on Myocardial Status in ICU Patients. Clinical Cardiology and Cardiovascular Interventions, 09(06), 01-03. https://doi.org/10.31579/2641-0419/550

Vancouver

Wasfy M, Farag M. Impact of Metabolic Syndrome on Myocardial Status in ICU Patients. Clinical Cardiology and Cardiovascular Interventions. 2026;09(06):01-03. doi:10.31579/2641-0419/550

BibTeX
@article{Wasfy2026,
  author = {Wasfy, Mohamed and Farag, Mohamed},
  title = {Impact of Metabolic Syndrome on Myocardial Status in ICU Patients},
  journal = {Clinical Cardiology and Cardiovascular Interventions},
  year = {2026},
  volume = {09},
  number = {06},
  pages = {01--03},
  doi = {10.31579/2641-0419/550}
}
Kostenlos starten →